Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).


TSXV:MPH - Post by User

Comment by Investorwpgon May 28, 2020 9:04am
233 Views
Post# 31081968

RE:Have to think he knows more than Mackie

RE:Have to think he knows more than Mackie

Nothing is happening at Medicure.  Bert Friesen is all about control.  He would rather own 100% of a $1 million company than 10% of a $100 million company.  That is why he agreed to do a share buyback at $6.50, which was valued at an astronomical premium to current market prices.  Some of the largest shareholders wanted out of their positions and threatened to remove him if he didn't agree to such a buyback.  Now Medicure is using its dwindling remaining cash to fund its losses, without the ability to conduct any transformative acquisitions.  Both Aggrastat and Zypitamag will face generic competition by 2023.  

Also, Bert donates a lot of shares each year to minimize his personal taxes.  I bet many of his recent purchases will be disposed of at year-end.

Another thing to remember is that Medicure funds several of Bert's non-profitable private companies.  Medicure pays Bert rent of over $200k per year, along with almost $750k per year to his privately owned companies: Genesys Venture, GVI CDS, and CanAm Bioresearch. 

Given the current economic climate, Medicure is the last place you would want to invest.
 

<< Previous
Bullboard Posts
Next >>